Question 1

What is the catalog number for β-Glucuronidase-IN-2?

Accepted Answer

The catalog number for β-Glucuronidase-IN-2 is T63250.

Question 2

What sizes are available for β-Glucuronidase-IN-2?

Accepted Answer

β-Glucuronidase-IN-2 is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does β-Glucuronidase-IN-2 come in?

Accepted Answer

β-Glucuronidase-IN-2 is available in 3 different pack sizes.

Question 4

Is β-Glucuronidase-IN-2 in stock?

Accepted Answer

β-Glucuronidase-IN-2 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures β-Glucuronidase-IN-2?

Accepted Answer

β-Glucuronidase-IN-2 is manufactured by Molfinity.

Question 6

What is the estimated delivery time for β-Glucuronidase-IN-2?

Accepted Answer

Estimated delivery time for β-Glucuronidase-IN-2 is approximately 10 business day(s), depending on your location.

Question 7

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 8

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 9

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

β-Glucuronidase-IN-2

Product Specifications

Target

Related Pathways

Bioactivity

Molecular Formula

Molecular Weight

Shipping Conditions

Storage Temperature

Available Sizes

Frequently Asked Questions

Explore Other Products

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)

Rovelizumab (Biosimilar Reference Antibody) (ITGAL)